JOYLYN CLUNY: Open Payments
NPI 1578603932 · HERRIMAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$333 in 15 payments from 7 companies in 2025. Trend: 2023 $305 · 2024 $291 · 2025 $333
Food & beverage: $333
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 9 | $237 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Boston Scientific Corporation | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: Korlym, CAPLYTA, ZORYVE, Wegovy, MOUNJARO, WaveWriter Alpha Prime 16, VRAYLAR.
Industry payments across UT — which companies pay providers there.
